ImportRefusal LogoImportRefusal

Aplicare Products, LLC

🚨 Critical Risk

FEI: 1220701 β€’ Meriden, CT β€’ UNITED STATES

FEI

FEI Number

1220701

πŸ“

Location

Meriden, CT

πŸ‡ΊπŸ‡Έ
🏒

Address

550 Research Pkwy, , Meriden, CT, United States

Critical Risk

FDA Import Risk Assessment

84.8
LowModerateHighCritical

This firm has an extensive history of FDA import refusals with severe violations.

Statistics

183
Total Refusals
6
Unique Violations
11/17/2025
Latest Refusal
6/8/2011
Earliest Refusal

Score Breakdown

Violation Severity
75.5Γ—40%
Refusal Volume
83.9Γ—30%
Recency
97.0Γ—20%
Frequency
100.0Γ—10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity β€” AI-assessed (1-10)
  • 30% Refusal Volume β€” Logarithmic scale
  • 20% Recency β€” Decays over 5 years
  • 10% Frequency β€” Refusals per year

Β© ImportRefusal.com Original Analysis

Violation Summary

27158Γ—

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

11815Γ—

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

328011Γ—

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

22801Γ—

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

3411Γ—

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

751Γ—

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/17/2025
62HBK99ANTI-MICROBIAL N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
9/11/2025
62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL)
3280FRNMFGREG
Division of Southwest Imports (DSWI)
5/5/2025
80LKBPAD, ALCOHOL, DEVICE DISINFECTANT
118NOT LISTED
Division of Southwest Imports (DSWI)
10/6/2023
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
2280DIRSEXMPT
Division of West Coast Imports (DWCI)
5/5/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/27/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/21/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/21/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/21/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/20/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/20/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/20/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
4/20/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/17/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
2/10/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/26/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)
1/25/2022
62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)
27DRUG GMPS
Division of Southwest Imports (DSWI)

Frequently Asked Questions

What is Aplicare Products, LLC's FDA import refusal history?

Aplicare Products, LLC (FEI: 1220701) has 183 FDA import refusal record(s) in our database, spanning from 6/8/2011 to 11/17/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Aplicare Products, LLC's FEI number is 1220701.

What types of violations has Aplicare Products, LLC received?

Aplicare Products, LLC has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Aplicare Products, LLC come from?

All FDA import refusal data for Aplicare Products, LLC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.